Delivery Order SPE2DR25D3505-SPE2DR26F96B8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/milliliter pharmaceutical product, valued at approximately $149.7K. The contract, issued on November 5, 2025, with completion by November 6, 2025, carries firm fixed-price terms with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $35,434.03 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of SKYRIZI 150 mg/mL pen injections. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the federal medical procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 21, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,796.82 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This firm fixed price delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of December 3, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order valued at $31,129.53 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen milliliter pharmaceutical product. This firm fixed-price delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- The Defense Logistics Agency awarded a $41,824.89 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication on September 2, 2025, with completion expected by September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under a larger procurement vehicle. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $18,153.63 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL medication on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $81,019.95 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml in pen form. This firm fixed price delivery order, issued on November 25, 2025, with completion targeted for November 26, 2025, represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,934.00 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML PEN/ML on December 2, 2025, with an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $27,346.09 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen milliliter pharmaceutical supplies on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of SKYRIZI 150 mg/mL pen medication, valued at $17,239.18. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The delivery is scheduled for completion by August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F96B8Delivery Order
The Defense Logistics Agency awarded a $24,934 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication on December 29, 2025, with completion expected by December 30, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical delivery supporting federal medical supply requirements, consistent with the agency's ongoing procurement of specialized pharmaceutical products for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor providing critical medical commodities including brand-name and generic medications, vaccines, and specialized healthcare supplies across multiple therapeutic domains. The company's federal procurement portfolio demonstrates extensive capability in fulfilling military healthcare requirements through open competition, serving customers including the Defense Health Agency and U.S. Coast Guard under flexible contract vehicles designed to support global pharmaceutical support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 12/28/25 |